Entrada Therapeutics Inc TRDA 深 滬
等待開盤 10-28 09:30:00 美东时间
4.41
-0.340
-7.16%
華盛通- 最 高4.85
- 今 開4.72
- 成交量 41.35万股
- 最 低 4.35
- 昨 收 4.75
- 總市值 1.72亿
- 52周最高 16.45
- 市盈率 靜 --
- 換手率 1.06%
- 52周最低 4.1092
- 委 比 13.12%
- 總股本 3893.67万
- 歷史最高 36.85
- 量 比 1.03
- 振 幅 10.53%
- 歷史最低 4.1092
- 每 手 1
- 風險率 2.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With Entrada Therapeutics Stock Wednesday?
On Wednesday, Entrada Therapeutics, Inc. (NASDAQ:TRDA) reported topline results from the first cohort of its Phase 1/2 ELEVATE-45-201 clinical trial. The study evaluates ENTR-601-45 in ambulatory patients who possess a Duchenne muscular dystrophy gene mutation suitable for exon 45 skipping. Followin...
10-15 00:47
Entrada Therapeutics reports positive ENTR-601-45 trial results
An announcement from Entrada Therapeutics Inc ( ($TRDA) ) is now available. On ...
10-14 20:20
Entrada Therapeutics Q2 EPS $(1.01) Beats $(1.09) Estimate, Sales $898.000K Beat $411.429K Estimate
Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.09) by 7.34 percent. This is a 2.88 percent increase over losses of $(1.04) per share from the same period last year. The company reported quarterly sales of $898.000 th...
08-05 19:34
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Entrada Advances Duchenne Muscular Dystrophy Drug to Higher Dose Cohort, Safety Review Clears Next Stage of Clinical Trial
Entrada Therapeutics, Inc. (NASDAQ:TRDA) today announced that an independent Data Monitoring Committee (DMC), per study protocol, has reviewed all available safety and PK data from the eight participants enrolled in
06-02 19:17
HC Wainwright & Co. Downgrades Entrada Therapeutics to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Entrada Therapeutics (NASDAQ:TRDA) from Buy to Neutral.
05-08 19:57
Dow Dips 350 Points; US Foods Posts Downbeat Earnings
Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US Foods reports lower Q1 earnings and sales. Agilon Health, Aaon, and Rackspace Technology see gains while Entrada, Fastly, and enGene Therapeutics decline. Euro zone and Asian markets mixed.
05-08 01:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Agilon Health (NYSE:AGL) shares moved upwards by 115.7% to $60.08 duri...
05-08 01:05
Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results.
Entrada Therapeutics shares are trading lower after the company reported mixed ...
05-07 20:46
Entrada posts strong ENTR-601-44 Duchenne Phase 1/2 data
Entrada Therapeutics Inc ( ($TRDA) ) has issued an announcement. On May 7, 2026...
05-07 19:55
